Dosing of second-generation antipsychotic medication in a state hospital system [2]

Journal of Clinical Psychopharmacology

Volumn 25, Issue 4, 2005, Pages 388-391

  Citrome, Leslie ^a,b   Jaffe, Ari ^a,b   Levine, Jerome ^a,b  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CHLORPROMAZINE; CLOZAPINE; FLUPHENAZINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

BIPOLAR DISORDER; DRUG DOSE REGIMEN; HUMAN; LETTER; MAJOR CLINICAL STUDY; MENTAL DISEASE; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; DRUG UTILIZATION REVIEW; FEMALE; HOSPITALS, PSYCHIATRIC; HOSPITALS, STATE; HUMANS; MALE; MIDDLE AGED; NEW YORK; PHYSICIAN'S PRACTICE PATTERNS; PSYCHOTIC DISORDERS;

EID: 23044440036     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000169623.30196.b9     Document Type: Letter

References (11)

1. Zito JM, Craig TJ, Wanderling J, et al. Pharmaco-epidemiology in 136 hospitalized schizophrenic patients. Am J Psychiatry. 1987; 144(6):778-782.
2. dosReis S, Zito JM, Buchanan RW, et al. Antipsychotic dosing and concurrent psychotropic treatments for Medicaid-insured individuals with schizophrenia. Schizophr Bull. 2002;28(4):607-617.
3. Sohler NL, Walkup J, McAlpine D, et al. Antipsychotic dosage at hospital discharge and outcomes among persons with schizophrenia. Psychiatr Serv. 2003;4(9):1258-1263.
4. Centorrino F, Eakin M, Bahk WM, et al. In-patient antipsychoticdruguse in 1998, 1993, and 1989. Am J Psychiatry. 2002;159(11):1932-1935.
5. Levine J, Jaffe AB. Antipsychotic medication utilization in a state mental hospital system, 1994-2000 Chap. 15. In: Manderscheid RW, Henderson MJ, eds. Mental Health United States 2002. Rockville, Md; Substance Abuse and Mental Health Services Administration. 2004:199-208. DHHS Pub Number (SMA) 3938.
6. Jaffe AB, Levine J. Antipsychotic medication coprescribing in a large state hospital system. Pharmacoepidemiol Drug Saf. 2003;12(1): 41-48.
7. Physicians' Desk Reference. 57th ed. 2003 Montvale, NJ: Thomson.
8. Davis JM, Chen N. Dose response and dose equivalence of antipsychotics. J Clin Psychopharmacol. 2004;24(2):192-208.
9. Citrome L, Volavka J. Optimal dosing of atypical antipsychotics in adults: a review of the current evidence. Harv Rev Psychiatry. 2002;10:280-291.
10. Citrome L, Jaffe A, Levine J. Monotherapy versus polypharmacy for hospitalized psychiatric patients. Am J Psychiatry. 2005;162(3):631.
11. Citrome L, Jaffe A, Levine J. Datapoints-use of mood stabilizers among patients with schizophrenia. 1994-2001. Psychiatr Serv. 2002; 53(10):1212.